anti-hiv agents

Preferred Label : anti-hiv agents;

MeSH definition : Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS.;

MeSH synonym : drugs, aids; anti-hiv drugs; anti-aids agents; drugs, anti-aids; aids drugs; agents, anti-hiv; anti hiv drugs; drugs, anti-hiv; agents, anti-aids; anti aids agents; anti-aids drugs; anti aids drugs; anti HIV agents; AIDS Drug; Drug, AIDS; Anti-AIDS Drug; Anti AIDS Drug; Drug, Anti-AIDS; Anti-HIV Agent; Agent, Anti-HIV; Anti HIV Agent; Anti-HIV Drug; Anti HIV Drug; Drug, Anti-HIV;

MeSH annotation : consider also AIDS /drug ther; may be used for articles on simian acquired immunodefic syndrome & simian immunodefic virus;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D019380;

UMLS CUI

C0376565;

ATC code(s)
- amprenavir [ATC Code]
- atazanavir [ATC Code]
- etravirine [ATC Code]
- fosamprenavir [ATC Code]
- tipranavir [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Anti-HIV Agent [NCIt concept]
Indexing information
- 1-(4-benzoyl-piperazin-1-yl)-2-(4-fluoro-7-(1,2,3)triazol-1-yl-1H-pyrrolo(2,3-c)pyridin-3-yl)-ethane-1,2-dione [MeSH Supplementary Concept]
- 2-(2-(5-nitro-2-thienyl)vinyl)quinoline [MeSH Supplementary Concept]
- 2-(4-((3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl)methyl))-1-piperazinyl-N-(4-methylphenyl)acetamide [MeSH Supplementary Concept]
- 3'-azido-3'-deoxythymidine-5'-bis(3,3-diacetoxy-propyl)phosphate [MeSH Supplementary Concept]
- 3alpha-2',2'-dimethylsuccinyl-14-taraxeren-28-acid [MeSH Supplementary Concept]
- 5,2',5'-trihydroxy-7,3',4'-trimethoxyflavone [MeSH Supplementary Concept]
- 6,7,11-trihydroxy-10-methoxy-9-(7-methoxy-3-methyl-1-oxoisochroman-5-yl)-2-methyl-12-oxo-12H-benzo(b)xanthene-4-carboxylic acid [MeSH Supplementary Concept]
- 6,7-dihydroxy-10,11-dimethoxy-9-(7-methoxy-3-methyl-1-oxoisochroman-5-yl)-2-methyl-12-oxo-12H-benzo(b)xanthene-4-carboxylic acid [MeSH Supplementary Concept]
- 6-phosphonylmethoxyethoxy-2,4-diaminopyrimidine [MeSH Supplementary Concept]
- BMS-986001 [MeSH Supplementary Concept]
- DNA-rAd5 vaccine [MeSH Supplementary Concept]
- IQP-0528 [MeSH Supplementary Concept]
- NM13 compound [MeSH Supplementary Concept]
- NSC-260594 [MeSH Supplementary Concept]
- RHI001 [MeSH Supplementary Concept]
- RHI002 [MeSH Supplementary Concept]
- S 1360 [MeSH Supplementary Concept]
- S-acyl-2-mercaptobenzamide thioester [MeSH Supplementary Concept]
- SPV 30 [MeSH Supplementary Concept]
- Tre-Recombinase [MeSH Supplementary Concept]
- VS411 drug combination [MeSH Supplementary Concept]
- aetheramide A [MeSH Supplementary Concept]
- aetheramide B [MeSH Supplementary Concept]
- antiviral 1592 [MeSH Supplementary Concept]
- bevirimat [MeSH Supplementary Concept]
- cabotegravir [MeSH Supplementary Concept]
- capravirine [MeSH Supplementary Concept]
- delvaridine [MeSH Supplementary Concept]
- ethyl 3-(2-naphthoyl)-7-isonicotinoylindolizine-1-carboxylate [MeSH Supplementary Concept]
- halopyridyl thiourea [MeSH Supplementary Concept]
- lamivudine-PEGylated chitosan [MeSH Supplementary Concept]
- leronlimab [MeSH Supplementary Concept]
- lexgenleucel-T [MeSH Supplementary Concept]
- m9 antibody [MeSH Supplementary Concept]
- methyl N-(N'-(3-O-(3',3'-dimethylsuccinyl)betulinic acid-28-oyl)-9-aminononanoyl)glutaminate [MeSH Supplementary Concept]
- neglignan B [MeSH Supplementary Concept]
- neglignan F [MeSH Supplementary Concept]
- sulfoquinovosyl diglyceride [MeSH Supplementary Concept]
- thiazolyl thiourea [MeSH Supplementary Concept]
- waltherione C [MeSH Supplementary Concept]
- waltherione-A [MeSH Supplementary Concept]
MedlinePlus topic(s)
- hiv/aids medicines [MedlinePlus Topic]
Record concept(s)
- Anti-HIV agents [MeSH concept]
See also
- antiretroviral therapy, highly active [MeSH Descriptor]
See also (suggested by CISMeF)
- acquired immunodeficiency syndrome [MeSH Descriptor]
- antiretroviral therapy, highly active [MeSH Descriptor]
- hiv infections [MeSH Descriptor]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 1-((2-hydroxyethoxy)methyl)-6-(phenylthio)thymine [MeSH Supplementary Concept]
- 2'3'-didehydro-2'3'-dideoxyadenosine [MeSH Supplementary Concept]
- 3'-deoxycytidine [MeSH Supplementary Concept]
- BMS-955176 [MeSH Supplementary Concept]
- Cobicistat [MeSH Descriptor]
- Dapivirine [MeSH Supplementary Concept]
- Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination [MeSH Descriptor]
- Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination [MeSH Descriptor]
- Emtricitabine [MeSH Descriptor]
- Emtricitabine, Rilpivirine, Tenofovir Drug Combination [MeSH Descriptor]
- Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination [MeSH Descriptor]
- GEM91 [MeSH Supplementary Concept]
- GS-9131 [MeSH Supplementary Concept]
- GSK-2838232 [MeSH Supplementary Concept]
- N-gamma-glutamylcysteine ethyl ester [MeSH Supplementary Concept]
- R-82913 [MeSH Supplementary Concept]
- Rilpivirine [MeSH Descriptor]
- TSAO-T [MeSH Supplementary Concept]
- Tenofovir [MeSH Descriptor]
- XZ456 [MeSH Supplementary Concept]
- XZ460 [MeSH Supplementary Concept]
- XZ462 [MeSH Supplementary Concept]
- abacavir [MeSH Supplementary Concept]
- abacavir, dolutegravir, and lamivudine drug combination [MeSH Supplementary Concept]
- aldesleukin [MeSH Supplementary Concept]
- aminomethyltrioxsalen [MeSH Supplementary Concept]
- azodicarbonamide [MeSH Supplementary Concept]
- cabotegravir, rilpivirine drug combination [MeSH Supplementary Concept]
- calanolide A [MeSH Supplementary Concept]
- capravirine [MeSH Supplementary Concept]
- carbovir [MeSH Supplementary Concept]
- cobicistat mixture with darunavir [MeSH Supplementary Concept]
- cosalane [MeSH Supplementary Concept]
- delavirdine [MeSH Descriptor]
- dexelvucitabine [MeSH Supplementary Concept]
- didanosine [MeSH Descriptor]
- dolutegravir, rilpivirine drug combination [MeSH Supplementary Concept]
- efavirenz, lamivudine, tenofovir disoproxil fumarate drug combination [MeSH Supplementary Concept]
- elsulfavirine [MeSH Supplementary Concept]
- elvitegravir [MeSH Supplementary Concept]
- emtricitabine tenofovir alafenamide [MeSH Supplementary Concept]
- hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine [MeSH Supplementary Concept]
- ibalizumab [MeSH Supplementary Concept]
- lamivudine [MeSH Descriptor]
- lamivudine, tenofovir disoproxil fumarate drug combination [MeSH Supplementary Concept]
- lamivudine, zidovudine drug combination [MeSH Supplementary Concept]
- lobucavir [MeSH Supplementary Concept]
- miglustat [MeSH Supplementary Concept]
- murabutide [MeSH Supplementary Concept]
- nevirapine [MeSH Descriptor]
- plerixafor [MeSH Supplementary Concept]
- pradimicin A [MeSH Supplementary Concept]
- recombinant soluble CD4 [MeSH Supplementary Concept]
- stavudine [MeSH Descriptor]
- stavudine, lamivudine, nevirapine drug combination [MeSH Supplementary Concept]
- tipranavir [MeSH Supplementary Concept]
- trichosanthin [MeSH Descriptor]
- troxacitabine [MeSH Supplementary Concept]
- ubenimex [MeSH Supplementary Concept]
- vMIP-II [MeSH Supplementary Concept]
- virion host shutoff protein, simplexvirus [MeSH Supplementary Concept]
- viscum album peptide [MeSH Supplementary Concept]
- zalcitabine [MeSH Descriptor]
- zidovudine [MeSH Descriptor]
- zidovudine triphosphate [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Anti-HIV Agent [NCIt concept]
- hiv/aids medicines [MedlinePlus Topic]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients